Fundalysisby DARKHORSESTOCKS

Scheme

Nippon India Pharma Fund

Holds 36 companies worth ₹8,919 Cr in Sept 2026.

  • Fund house

    NipponThe fund house that runs this scheme.

  • AUM

    ₹9,166 CrNippon India Pharma Fund's AUM at the end of 30 Sept 2026, as AMFI reports it. Down 3.3% on Aug 2026, ₹9,479 Cr.

  • Largest holding

    Sun Pharmaceutical Ind LtdSun Pharmaceutical Ind Ltd is 11.7% of this scheme's NAV.

  • Fund manager

    Sailesh Raj BhanRuns it since 1 Jun 2004, as the fund house dates it.

AUM(Jun 2010 – Sept 2026)

AUM at month end each month, and its change on the month before
12 months₹ CrChange
Sept 20269,166−3.3%
Aug 20269,479+2.2%
Jul 20269,279+2.6%
Jun 20269,044+4.7%
May 20268,635+3.2%
Apr 20268,365+5.9%
Mar 20267,898−4.9%
Feb 20268,306+5.5%
Jan 20267,877−4.7%
Dec 20258,265−2.3%
Nov 20258,459+1.3%
Oct 20258,346+2.9%
AUM at month end, Sept 2026
₹9,166 Cr
+9.8% since Oct 2025
Fig. 1.AUM at each month's end, ₹ crore; under All, the quarterly average since 2010. Source: AMFI.

Direct plans(Mar 2013 – Sept 2026)

Direct plans' share of AUM each quarter, and its change on the quarter before
4 quartersShareChange
Sept 202627.19%+0.30 pt
Jun 202626.88%+0.22 pt
Mar 202626.66%−0.08 pt
Dec 202526.74%−0.02 pt
Direct plans' share of AUM, Sept 2026
27.19%
+0.44 pt since Dec 2025
Fig. 2.Nippon India Pharma Fund's quarterly average AUM in direct plans, which pay no distributor; changes in points. Source: AMFI.

Returns(9 Oct 2026)

Growth · Direct and Regular plans

To 9 Oct 2026; past a year, a yearly rate. Benchmark: BSE Healthcare TRI. * From NAVs. Source: AMFI. Click a column's header to sort by it.
1 month *
−4.94%−5.01%––−3.88%
3 months *
−2.85%−3.06%––−3.17%
6 months *
+10.37%+9.91%––+6.47%
1 year
+8.01%+7.07%+10.89%−2.88 pt+4.55%
3 years
+17.16%+16.12%+21.02%−3.86 pt+16.67%
5 years
+12.97%+11.96%+13.93%−0.96 pt+14.19%
10 years
+15.14%+14.12%+12.32%+2.82 pt+15.14%
Since launch
+17.06%+19.56%+14.55%+2.50 pt+14.63%
Fig. 3.To 9 Oct 2026; past a year, a yearly rate. Benchmark: BSE Healthcare TRI. * From NAVs. Source: AMFI.